Literature DB >> 25320261

Parathyroid adenoma in a patient with familial hypocalciuric hypercalcaemia.

Hannah Elizabeth Forde1, Arnold D Hill2, Diarmuid Smith3.   

Abstract

A 57-year-old man with symptoms of fatigue, joint pains and insomnia was found to have hypercalcaemia secondary to hyperparathyroidism with a corrected calcium of 2.61 mmol/L (2.2-2.6 mmol/L) and a serum parathyroid hormone (PTH) of 86 pg/mL (10-65 pg/mL). Preoperative workup demonstrated a parathyroid adenoma in the right upper position and he proceeded to surgery. Postoperatively, however, his symptoms remained unchanged and the corrected calcium remained elevated at 2.87 mmol/L with a PTH of 59 pg/mL. He had no family history of hypercalcaemia. Further investigations revealed low 24 h urinary calcium level and a low urine calcium to creatinine ratio. Genetic testing revealed a mutation in exon 4 of the calcium sensing receptor (CaSR) confirming a diagnosis of familial hypocalciuric hyercalcaemia (FHH). The case is an example of a rare phenomenon when a parathyroid adenoma develops in patients with FHH. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25320261      PMCID: PMC4202059          DOI: 10.1136/bcr-2014-206473

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

Review 1.  Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.

Authors:  John P Bilezikian; John T Potts; Ghada El-Hajj Fuleihan; Michael Kleerekoper; Robert Neer; Munro Peacock; Jonas Rastad; Shonni J Silverberg; Robert Udelsman; Samuel A Wells
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

2.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

3.  Parathyroid adenoma in a subject with familial hypocalciuric hypercalcemia: coincidence or causality?

Authors:  K Burski; B Torjussen; A Q Paulsen; H Boman; J Bollerslev
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

4.  Normalization of serum calcium by cinacalcet in a patient with hypercalcaemia due to a de novo inactivating mutation of the calcium-sensing receptor.

Authors:  H J L M Timmers; M Karperien; N A T Hamdy; H de Boer; A R M M Hermus
Journal:  J Intern Med       Date:  2006-08       Impact factor: 8.989

Review 5.  Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications.

Authors:  Leslie S Eldeiry; Daniel T Ruan; Edward M Brown; Jason L Gaglia; Jeffrey R Garber
Journal:  Endocr Pract       Date:  2012 May-Jun       Impact factor: 3.443

6.  Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.

Authors:  Andrew Grey; Jenny Lucas; Anne Horne; Greg Gamble; James S Davidson; Ian R Reid
Journal:  J Clin Endocrinol Metab       Date:  2005-01-11       Impact factor: 5.958

Review 7.  Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism.

Authors:  Myrick C Shinall; Kathryn McCrystal Dahir; James T Broome
Journal:  Endocr Pract       Date:  2013 Jul-Aug       Impact factor: 3.443

Review 8.  Vitamin D deficiency and primary hyperparathyroidism.

Authors:  Shonni J Silverberg
Journal:  J Bone Miner Res       Date:  2007-12       Impact factor: 6.741

9.  Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.

Authors:  Signe Engkjaer Christensen; Peter H Nissen; Peter Vestergaard; Lene Heickendorff; Lars Rejnmark; Kim Brixen; Leif Mosekilde
Journal:  Eur J Endocrinol       Date:  2008-09-11       Impact factor: 6.664

10.  Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case series.

Authors:  Anne Qvist Rasmussen; Niklas Rye Jørgensen; Peter Schwarz
Journal:  J Med Case Rep       Date:  2011-12-05
View more
  7 in total

Review 1.  Familial hypocalciuric hypercalcemia and related disorders.

Authors:  Janet Y Lee; Dolores M Shoback
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-05-26       Impact factor: 4.690

2.  Multiple endocrine neoplasia phenocopy revealed as a co-occurring neuroendocrine tumor and familial hypocalciuric hypercalcemia type 3.

Authors:  Silje Hovden; Marie Louise Jespersen; Peter H Nissen; Per Løgstrup Poulsen; Lars Rolighed; Søren A Ladefoged; Lars Rejnmark
Journal:  Clin Case Rep       Date:  2016-08-18

Review 3.  Diseases associated with calcium-sensing receptor.

Authors:  C Vahe; K Benomar; S Espiard; L Coppin; A Jannin; M F Odou; M C Vantyghem
Journal:  Orphanet J Rare Dis       Date:  2017-01-25       Impact factor: 4.123

4.  Case Report: Familial Hypocalciuric Hypercalcaemia and Hashimoto's Thyroiditis.

Authors:  Shahd Mobarak; Munir Tarazi; Harry Spiers; Anjali Santhakumar; Bence Forgacs
Journal:  Front Surg       Date:  2020-06-16

5.  Radiofrequency Ablation of Parathyroid Glands to Treat a Patient With Hypercalcemia Caused by a Novel Inactivating Mutation in CaSR.

Authors:  Yu Hao; Zhikai Lei; Nanjing Shi; Lingying Yu; Weiqin Ji; Xianfeng Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-14       Impact factor: 5.555

6.  A NOVEL MUTATION IN CALCIUM-SENSING RECEPTOR PRESENTING AS FAMILIAL HYPOCALCIURIC HYPERCALCEMIA IN A YOUNG MAN.

Authors:  Parvathy Madhavan; Thi Hong Van Do; Allen Bale; Sachin Majumdar
Journal:  AACE Clin Case Rep       Date:  2019-03-13

7.  Double jeopardy: a patient's tale of two concurrent hypercalcaemic syndromes.

Authors:  Aditi Sharma; Fatima Bahowairath; Chukwuma Uduku; Julia E Ostberg
Journal:  BMJ Case Rep       Date:  2020-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.